Analysis for Itaúsa (preferred/PN)
Analysis summary
Itaúsa (preferred/PN) (ITSA4.BR) currently has a total score of 75 points, placing it in the strong range. The score is made up of Performance (71), Stability (74) and Trend (86). All three sub-scores are currently above average.
Performance scores 71 points (strong). Key strength: 1Y return at 54.2 %. Even the weakest return is still strong in absolute terms: 5Y return at 81.3 %. This points to a sharper upswing more recently.
Stability scores 74 points (strong). Key strength: Sharpe ratio (90d) at 2.08. Main drag: max drawdown (5Y) at -40.7 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 86 points (very strong). Key strength: Price is about 15.8 % above SMA50. Even the weakest metric remains solid in absolute terms: relative strength (12M) at 22.5 %.
Overall, the score is shaped most by Trend; Performance trails and dampens the total. On a metric level, SMA50 distance stands out, while max drawdown (5Y) is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does Itaúsa (preferred/PN) fit best in FoxScore?
- Itaúsa (preferred/PN) fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
- How meaningful is the available history for Itaúsa (preferred/PN)?
- Itaúsa (preferred/PN) currently has about 15 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.